{
    "clinical_study": {
        "@rank": "93910", 
        "acronym": "BOOGIE", 
        "arm_group": {
            "arm_group_label": "Intervention group", 
            "arm_group_type": "Experimental", 
            "description": "Healthy infants receiving standard cow's milk-based infant formula with added prebiotic oligosaccharides, and a modified fat blend and protein composition."
        }, 
        "brief_summary": {
            "textblock": "This study is initiated to investigate the gastrointestinal tolerance of a new infant\n      formula in healthy, term, Asian infants."
        }, 
        "brief_title": "Gastrointestinal Tolerance Study of a New Infant Formula", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Infants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy, well-nourished,  term, Asian infants (gestational age \u2265 37 1/7 and \u2264 41 6/7\n             weeks)\n\n          -  The mother had unequivocally decided not to exclusively breast-feed\n\n          -  Formula fed for at least one week, receiving at least two formula feedings per day\n\n          -  Birth weight appropriate for gestational age (AGA), 2500-4000g\n\n          -  Written informed consent from parent(s) and/or legal guardian, aged \u2265 18 years.\n\n        Exclusion Criteria:\n\n          -  Age > 17 weeks\n\n          -  Infants known to have current or previous illnesses/conditions or intervention which\n             could interfere with the study (impacting tolerance and/or growth), such as\n             gastrointestinal malformations, chronic diarrhoea, malabsorptive syndrome,\n             malnutrition, congenital immunodeficiency,  or major surgery, as per investigator's\n             clinical judgement\n\n          -  Infants who suffered from gastroenteritis or diarrhoea in the last 4 weeks preceding\n             study start.\n\n          -  Infants who used any medication or nutritional supplements (except for vitamin\n             supplementation to complement breastfeeding) in the 4 weeks preceding study start.\n\n          -  Infants who have medical conditions for which a special diet other than standard (non\n             hydrolysed) cow's milk-based infant formula is required (such as cow's milk allergy,\n             soy protein allergy, fish protein allergy, egg protein allergy, lactose intolerance,\n             galactosemia).\n\n          -  Infants with any history of or current participation in any other study involving\n             investigational or marketed products.\n\n          -  Investigator's uncertainty about the willingness or ability of the parents to comply\n             with the protocol requirements."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Weeks", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681355", 
            "org_study_id": "BLU.1.C/A"
        }, 
        "intervention": {
            "arm_group_label": "Intervention group", 
            "description": "Standard cow's milk based infant formula with added prebiotic oligosaccharides, and a modified fat blend and protein composition", 
            "intervention_name": "Infant Formula", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Healthy, term, Asian infants", 
            "Infant formula"
        ], 
        "lastchanged_date": "January 8, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bantul", 
                        "country": "Indonesia", 
                        "state": "DIY Yogyakarta"
                    }, 
                    "name": "Panembahan Senopati Distric Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yogyakarta", 
                        "country": "Indonesia", 
                        "state": "DIY Yogyakarta"
                    }, 
                    "name": "Sakina Idaman Mothers and Children Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bangkok", 
                        "country": "Thailand"
                    }, 
                    "name": "King Chulalongkorn Memorial Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hat Yai", 
                        "country": "Thailand"
                    }, 
                    "name": "Prince of Songkhla University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Khon Kaen", 
                        "country": "Thailand"
                    }, 
                    "name": "Khon Kaen University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Indonesia", 
                "Thailand"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Open-label Study to Evaluate the Gastrointestinal Tolerance of a New Infant Formula in Healthy, Term, Asian Infants", 
        "other_outcome": [
            {
                "measure": "Anthropometry", 
                "safety_issue": "Yes", 
                "time_frame": "Week 3, Week 6"
            }, 
            {
                "measure": "Use of medication and nutritional supplements", 
                "safety_issue": "Yes", 
                "time_frame": "Week 1, Week 3, Week 6 and Week 8"
            }, 
            {
                "measure": "Number, type and severity of (serious) adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Week 1, Week 3, Week 6 and Week 8"
            }
        ], 
        "overall_official": {
            "affiliation": "Danone Research", 
            "last_name": "Jan van der Mooren, PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Gastrointestinal tolerance is measured by stool consistency and gastrointestinal symptoms.", 
            "measure": "Gastrointestinal tolerance", 
            "safety_issue": "No", 
            "time_frame": "up to Week 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681355"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Danone Asia Pacific Holdings Pte, Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Danone Asia Pacific Holdings Pte, Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}